Publication: Glucose-6-phosphate dehydrogenase a novel hope on a blood-based diagnosis of Alzheimer’s disease
Loading...
Program
KU-Authors
Organization Authors
Co-Authors
Evlice, Ahmet
Date
Language
Type
Embargo Status
N/A
Journal Title
Journal ISSN
Volume Title
Alternative Title
Abstract
Alzheimer’s disease (AD) is a multi-factorial neurodegenerative disorder that numerous factors have key properties in the development of this proteopathy. Glucose-6-phosphate dehydrogenase (G6PD) is the most common form of enzymopathy. We have examined G6PD enzyme activity levels in the serum of newly diagnosed AD patients compared with control subjects without dementia from the both sexes. Serum G6PD levels were found to be significantly higher (approximately two times) in AD patients compared to control geriatric subjects in both sexes. We have concluded that G6PD seems to play an integral role in the progress and/or prevention of AD.
Source
Publisher
Springer
Subject
Citation
item.page.haspartof
Source
Acta neurologica belgica
item.page.ispartofseries
item.page.edition
DOI
10.1007/s13760-016-0666-6
item.page.datauri
item.page.link
Rights
N/A
Copyrights Note
Rights and licensing
N/A